Leucadia National - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 138 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
Leucadia National ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,937,157
-33.7%
835,561
+9.9%
0.12%
-33.5%
Q2 2023$21,006,695
+1825.5%
760,561
+660.6%
0.19%
+2250.0%
Q4 2022$1,091,000100,0000.01%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$40,852,37215.05%
Kynam Capital Management, LP 1,818,657$30,335,1994.96%
BVF INC/IL 5,744,848$95,824,0652.58%
Ghost Tree Capital, LLC 400,000$6,672,0002.19%
COWEN AND COMPANY, LLC 1,657,551$27,647,9501.93%
RTW INVESTMENTS, LP 5,415,514$90,330,7741.91%
Sio Capital Management, LLC 248,127$4,138,7581.28%
683 Capital Management, LLC 732,784$12,222,8370.95%
Artia Global Partners LP 112,340$1,873,8310.78%
Perceptive Advisors 1,054,273$17,585,2740.59%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders